Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 10;6(15):10242-10249.
doi: 10.1021/acsomega.1c00580. eCollection 2021 Apr 20.

A Novel Mechanical-Based Injective Hydrogel for Treatment with Aromatase Inhibitors Caused Joint Inflammation via the NF-κB Pathway

Affiliations

A Novel Mechanical-Based Injective Hydrogel for Treatment with Aromatase Inhibitors Caused Joint Inflammation via the NF-κB Pathway

Zipeng Yang et al. ACS Omega. .

Abstract

Synovium has widely participated in induced inflammation, suggesting that it is a potential target to reduce aromatase inhibitors (AIs) causing joint inflammation or pain. Exercise and mechanical stimulation are important strategies for precaution and treatment of bone inflammation. In this work, we developed a novel thermo-sensitive hydrogel, which could be injected intra-articularly. The aim of this research was to investigate the role of various mechanical strength hydrogels in reducing synovium inflammation. The effect of different mechanical strength hydrogels on regulating synovium inflammation was used to stimulate human fibroblast-like synoviocytes (FLS) under a cyclic mechanical compression environment in vitro. Cytokine and metalloprotease expression in FLS was analyzed by the western blot and q-PCR method, in which FLS were cultured with the different mechanical strength hydrogels. The results showed that a moderate-intensity hydrogel mechanical stimulation might be suitable in reducing AI-induced FLS inflammation via the NK-κB pathway. In addition, we built an AI-treated rat model and injected the different mechanical strength hydrogels. Similarly, the moderate-strength mechanical hydrogel could reduce the inflammatory factor and metalloproteinase expression in synovial tissues and intra-articular synovia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
(A) Synthetic circuit diagram of gelatin-grafted Pluronic; (B) images of the hydrogel production process; (C) 1H NMR spectra of Pluronic, gelatin, and GP; (D) phase diagram of Pluronic and GP; (E) oscillatory frequency sweep tests (at a strain of 0.05%) at 37 °C; and (F) SEM images of GP hydrogels of different stiffness values.
Figure 2
Figure 2
Synovial fibroblasts’ cell viability cultured with low-intensity, moderate-intensity, and high-intensity hydrogels at different times. (A) The cells were stained by vimentin immunofluorescence and DAPI. (B) The cell proliferation rate was measured by the MTT method.
Figure 3
Figure 3
Synovial fibroblasts’ cell viability cultured with low-intensity, moderate-intensity, and high-intensity hydrogels at 72 h at cyclic compression pressure. The cells apoptosis was analyzed by flow cytometry.
Figure 4
Figure 4
The effect of different mechanical intensities of the hydrogel on inflammatory agent mRNA expression in the FLS was demonstrated. The mRNA expression levels of bone markers IL-1β (A), IL-6 (B), TNF-α (C), and MMP-1 (D) at 24 h were detected by qPCR.
Figure 5
Figure 5
Western blotting showed protein levels of p-IKBα, IKBα, p-p65, p65, IL-6, and MMP-1 at 24 h (A). Statistical analysis of the relative protein expression of p-p65/p65 (B), IL-6 (C), and MMP-1 (D) at 24 h. All data are the average values from several independent experiments (n = 3). *P < 0.05, **P < 0.01 vs the control group.
Figure 6
Figure 6
Immunohistochemical image of IL-6 (A) and MMP-1 (C) expressions in synovial tissues after injection of different strength hydrogels at week 2. Quantitative analysis of IL-6 (B) and MMP-1 (D) expressions in intra-articular synovia after injection of different strength hydrogels at week 2. All experiments were conducted in triplicate. *P < 0.05, **P < 0.01 vs the control group. The scale bars are 200 (A) and 30 μm (C), respectively.

Similar articles

Cited by

References

    1. Irwin M. L.; Cartmel B.; Gross C. P.; Ercolano E.; Li F.; Yao X.; Fiellin M.; Capozza S.; Rothbard M.; Zhou Y.; et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J. Clin. Oncol. 2015, 33, 1104–1111. 10.1200/JCO.2014.57.1547. - DOI - PMC - PubMed
    1. Wright L. E.; Harhash A. A.; Kozlow W. M.; Waning D. L.; Regan J. N.; She Y.; John S. K.; Murthy S.; Niewolna M.; Marks A. R.; Mohammad K. S.; Guise T. A. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget 2017, 8, 8406–8419. 10.18632/oncotarget.14139. - DOI - PMC - PubMed
    1. Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann. Oncol. 2013, 24, 1443–1449. 10.1093/annonc/mdt037. - DOI - PubMed
    1. van Hellemond I. E. G.; Geurts S. M. E.; Tjan-Heijnen V. C. G. Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer. Curr. Treat. Options Oncol. 2018, 19, 26.10.1007/s11864-018-0541-1. - DOI - PMC - PubMed
    1. Chim K.; Xie S. X.; Stricker C. T.; Li Q. S.; Gross R.; Farrar J. T.; DeMichele A.; Mao J. J. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors. BMC Cancer 2013, 13, 401.10.1186/1471-2407-13-401. - DOI - PMC - PubMed

LinkOut - more resources